Elite Pharmaceuticals Inc (ELTP)

[Couch]

I guess the question you have to ask is do you believe that Nasrat Hakim is serious about getting that twice daily ART opioid to market by the end of 2015.....and if he does what does that do to the current PPS? Then you have to ask in relation to Elite starting all these studies/trials....where are they going to get the funds to pay for all of these various studies and trials?

In essence, the company says it needs to put out generic products to garner revenue to support its operations....it has done this moving towards covering its R&D costs next......tells you it needs funding and JT first secures funding from Socius and puts that on the back burner till it secures the LPC funding.........then hires a top notch Big Pharma executive from Actavis as its CEO....who reinitiates Elite's ART studies/trials after a 7 year hiatus......what's next? Putting the ART products on the market.

Clear to me that $39.5 million dollars worth of preferred I shares is going to be used to move this company to the next level of play. The PPS will follow.

Money to pay for trials, entice a partner, help with a merger or acquisition....take your pick. Bottom line Nasrat was hired to move us to the Nasdaq using his connections in the pharma space.